Candesartan cilexetil 32 MG TB 90S
Ended Awarded
- Contract number
- SPE2DB26FH6NQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,441
Award facts
- Contract value 100% obligated
- $16,440.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count) with a ceiling value of $16,440.76. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, carries no set-aside designation and was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Candesartan Cilexetil is an angiotensin II receptor blocker used for hypertension management, reflecting the pharmaceutical distributor's role in supplying critical medications for military and federal healthcare systems.
This delivery order represents one of numerous orders issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract authorizes AmerisourceBergen to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's federal procurement activities demonstrate its position as a major pharmaceutical distributor serving the Defense Logistics Agency's medical supply chain across multiple therapeutic domains and product categories.
Quick answers
Who was awarded contract SPE2DB26FH6NQ?
SPE2DB26FH6NQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FH6NQ worth?
The government has obligated $16,441 on SPE2DB26FH6NQ.
Is contract SPE2DB26FH6NQ an order under another contract?
Yes. SPE2DB26FH6NQ is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB26FH6NQ competed?
The extent of competition for SPE2DB26FH6NQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award